Each test is selected based on your unique presentation, goals, and risk profile, never a one-size-fits-all protocol
Clinical studies Compared with the considerable amount of pre-clinical and mechanistic research reported above, we identified few clinical studies of GLP-1RAs for substance-use disorders (Table 2): three for alcohol 111,112,113 , one for cannabis 114 , two for cocaine 115,116 and two for nicotine 117,118 , while no article about opiates or amphetamines was retrieved
This call offers you the chance to delve into questions about peptide protocols, research, and where to begin
Thank you for being a wonderful human and friend
Long-term safety studies (beyond 6 months) do not appear to have been conducted for oral glutathione [1]